A Current Review of Targeted Therapeutics for Ovarian Cancer

Abstract

Difficult to detect, ovarian cancer typically presents at an advanced stage. Significant progress has been achieved in the treatment of ovarian cancer with therapeutics focused on DNA replication or cell division. However, despite sensitivity to induction chemotherapy the majority of patients will develop recurrent disease. Conventional agents for recurrent… (More)
DOI: 10.1155/2010/149362

Topics

6 Figures and Tables